PC
COLL icon

Pier Capital’s Collegium Pharmaceutical COLL Stock Holding History

Pier Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-395,658
Closed -$4.95M – 111
2017
Q2 		$4.95M Buy
395,658
+29,594
+8% +$292K 0.85% 78
2017
Q1 		$3.68M Buy
366,064
+36,435
+11% +$542K 0.63% 93
2016
Q4 		$5.13M Buy
329,629
+284,929
+637% +$4.74M 0.93% 71
2016
Q3 		$861K Buy
+44,700
New +$531K 0.15% 104

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pier Capital's COLL Position: Q3 2017 in Review

Pier Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2017, closing a stake of 395,658 shares — an estimated $4.95M sold.

Pier Capital first reported a position in COLL in Q3 2016 and held it in 4 quarters. The position peaked at $5.13M in Q4 2016. 75 funds tracked by Wall St. Rank hold COLL as of Q3 2017.

  • Pier Capital reported no remaining Collegium Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Pier Capital sold 395,658 Collegium Pharmaceutical shares in Q3 2017, an estimated $4.95M.
  • Pier Capital first reported a position in Collegium Pharmaceutical in Q3 2016 and held it in 4 quarters.
  • Pier Capital's Collegium Pharmaceutical position peaked at $5.13M in Q4 2016.
  • 75 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2017.

Based on Pier Capital's 13F filing for Q3 2017, filed 13 Nov 2017.